Stock analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a report released on Tuesday. The firm set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Price Performance
NYSE:CO opened at $1.50 on Tuesday. The firm’s 50 day simple moving average is $1.36 and its 200 day simple moving average is $1.36. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50. The company has a market cap of $182.33 million, a PE ratio of 2.34 and a beta of 0.16.
About Global Cord Blood
Further Reading
- Five stocks we like better than Global Cord Blood
- What is a buyback in stocks? A comprehensive guide for investors
- Autodesk Stock: Analysts’ Top AI Pick You Shouldn’t Overlook
- Stock Dividend Cuts Happen Are You Ready?
- Hidden Opportunities in Li Auto’s Tough Quarter You Can’t Miss
- How to Choose Top Rated Stocks
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.